Lyra Medical

Lyra Medical has developed a new implant for the surgical treatment of pelvic organ prolapse (POP). The company’s self-retaining support (SRS) technology eliminates the need for complex anchoring techniques to assure a safe, easy to use and long-term treatment solution. The anchorless solution mimics the physiologic support, pubocervical fascia, restoring pelvic organs to their anatomical and functional location. The SRS Implant is the only product that has delivered exceptional safety and long-term efficacy through clinical trials prior to being approved for general use. The SRS Implant is currently available for use in Europe, Central America and Israel.